Your session is about to expire
← Back to Search
Patient Navigator Services for Lupus
N/A
Waitlist Available
Led By Jim C. Oates, MD
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months - from baseline to 12 month visit
Awards & highlights
Study Summary
This trial will use targeted interventions to address common barriers to care among patients with SLE, in order to improve health outcomes for minority groups. A patient navigator will provide services such as transportation and financial assistance, appointment scheduling, and education and support.
Eligible Conditions
- Lupus
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months - from baseline to 12 month visit
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months - from baseline to 12 month visit
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Improvement in Medication Adherence
Secondary outcome measures
Improvement in Adherence with medical providers and services
Improvement in patient-reported lupus-specific disease status
Trial Design
1Treatment groups
Experimental Treatment
Group I: Interventional GroupExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient Navigator Services
2020
N/A
~30
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamOTHER
1,581 Previous Clinical Trials
2,278,003 Total Patients Enrolled
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
483 Previous Clinical Trials
1,086,914 Total Patients Enrolled
2 Trials studying Lupus
270 Patients Enrolled for Lupus
Medical University of South CarolinaLead Sponsor
932 Previous Clinical Trials
7,394,234 Total Patients Enrolled
1 Trials studying Lupus
120 Patients Enrolled for Lupus
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there an ongoing recruitment for participants in this research project?
"Per the records on clinicaltrials.gov, applications for this study are closed as of June 22nd 2022. This research began accepting candidates on September 3rd 2020 and unfortunately has now reached their participant quota; however, 125 other studies remain open to new patients at present."
Answered by AI
Share this study with friends
Copy Link
Messenger